Citation Impact
Citing Papers
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
Sequence and exon-intron organization of the DNA encoding the alpha I domain of human spectrin. Application to the study of mutations causing hereditary elliptocytosis.
1989 StandoutNobel
A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri
1988
Endometriotic disease: the role of peritoneal fluid
1998
Guidelines of care for acne vulgaris management
2007
Alpha-Linolenic Acid: Is It Essential to Cardiovascular Health?
2010
An overview of environmental risk factors in systemic sclerosis
2015
Current Concepts in the Pathogenesis of Endometriosis
1999
Gonadotrophin-releasing hormone analogues for pain associated with endometriosis
1999
Molecular analysis of insertion/deletion mutations in protein 4.1 in elliptocytosis. I. Biochemical identification of rearrangements in the spectrin/actin binding domain and functional characterizations.
1990 StandoutNobel
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
Treatment of hirsutism with lowest-dose flutamide (62.5 mg/day)
2000
Skin aging and sex hormones in women – clinical perspectives for intervention by hormone replacement therapy
2004
Is dehydroepiandrosterone a hormone?
2005
Endometriosis
2009 Standout
Pain scoring in endometriosis: entry criteria and outcome measures for clinical trials. Report from the Art and Science of Endometriosis meeting
2008
Systemic sclerosis
2017 Standout
Increased secretion of hepatocyte growth factor by eutopic endometrial stromal cells in women with endometriosis
1997
Thiazolidinedione Inhibition of Peritoneal Inflammation
2003
Network antibodies identify nuclear lamin B as a physiological attachment site for peripherin intermediate filaments
1991 StandoutNobel
Oxidative stress and peritoneal endometriosis
2002
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis
2013
Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study
1998
Treatment of uterine leiomyomata with a luteinizing hormonereleasing hormone agonist: the possibility of nonsurgical management in selected perimenopausal women
1991
Polycystic Ovary Syndrome
1995 Standout
Uterine fibroids
2001 Standout
Ovulation suppression for endometriosis
2003
Endometrial alterations in endometriosis: a systematic review of putative biomarkers
2011
Endometriotic Lesions Synthesize and Secrete a Haptoglobin-Like Protein1
1998
Acne vulgaris
2011 Standout
Polycystic Ovary Syndrome
2005 Standout
Endometriosis
2010 Standout
Non-canonical inflammasome activation targets caspase-11
2011 StandoutNature
Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis
2002
Macrophages, Oxidation, and Endometriosis
2002
Treatment of hirsutism with the pure antiandrogen flutamide
1990
Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause
2007 Standout
Identification of Macrophage Migration Inhibitory Factor as a Potent Endothelial Cell Growth-Promoting Agent Released by Ectopic Human Endometrial Cells 1
2000
Endometriosis
2004 Standout
Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix
1998
Structure of the Calmodulin αII-Spectrin Complex Provides Insight into the Regulation of Cell Plasticity
2006 StandoutNobel
Linkage of Dominant Hereditary Spherocytosis to the Gene for the Erythrocyte Membrane-Skeleton Protein Ankyrin
1990 StandoutNobel
Conjugated Equine Estrogens and Coronary Heart Disease
2006
Cardioprotection by chronic estrogen or superoxide dismutase mimetic treatment in the aged female rat
2004
Co-expression of Defective Luteinizing Hormone Receptor Fragments Partially Reconstitutes Ligand-induced Signal Generation
1997 StandoutNobel
Medical management of endometriosis and infertility
2000
Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis
2002
Two-step gonadotropin-releasing hormone agonist treatment of uterine leiomyomas: Standard-dose therapy followed by reduced-dose therapy
1996
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen
2000
Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages
2016 Standout
Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study
1990
The calmodulin-binding site in alpha-fodrin is near the calcium-dependent protease-I cleavage site.
1988
Discrete changes of cell membrane capacitance observed under conditions of enhanced secretion in bovine adrenal chromaffin cells.
1982 StandoutNobel
A structural model of human erythrocyte spectrin. Alignment of chemical and functional domains.
1982
Endgoenous protein kinase in outer plasma membrane of cultured 3T3 cells. Nature of the membrane-bound substrate and effect of cell density, serum addition, and oncogenic transformation
1976
Non-Peptide Gonadotropin-Releasing Hormone Receptor Antagonists
2008
Pathogenesis and pathophysiology of endometriosis
2012 Standout
Identification, purification, and partial characterization of a novel Mr 28,000 integral membrane protein from erythrocytes and renal tubules.
1988 StandoutNobel
An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
1993
INHIBITORY ACTIVITY OF ANALOGUES OF LUTEINIZING HORMONE‐RELEASING HORMONE (LH‐RH) IN VITRO AND IN VIVO
1976 StandoutNobel
Hepatic alpha-adrenergic receptors. Identification and subcellular localization using [3H]dihydroergocryptine.
1978 StandoutNobel
Actin from Saccharomyces cerevisiae.
1982 StandoutNobel
Hypothalamic Regulatory Hormones
1973 StandoutScienceNobel
Cyclic AMP levels and types I and II cyclic AMP-dependent protein kinase activity in synchronized cells and in quiescent cultures stimulated to proliferate
1978
Endometriosis: The Role of Neuroangiogenesis
2011
Granulosa Cells as Hormone Targets: The Role of Biologically Active Follicle-Stimulating Hormone in Reproduction
1989
Alteration of the erythrocyte membrane skeletal ultrastructure in hereditary spherocytosis, hereditary elliptocytosis, and pyropoikilocytosis
1990 StandoutNobel
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Identification of functional domains of human erythrocyte spectrin.
1980
HORMONE SECRETION BY CELLS DISSOCIATED FROM RAT ANTERIOR PITUITARIES
1973
Epidermal growth factor and basic fibroblast growth factor in peritoneal fluid of women with endometriosis
1996
The Calpain System
2003 Standout
Mutant forms of spectrin alpha-subunits in hereditary elliptocytosis.
1987 StandoutNobel
Analysis of the karyotype and desoxyribonucleic acid content of uterine myomas in premenopausal, menopausal, and gonadotropin-releasing hormone agonist-treated females
1996
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Comparative Effects of Cyproterone Acetate or a Long-Acting Gonadotropin-Releasing Hormone Agonist in Polycystic Ovarian Disease
1986
Blood biomarkers for the non-invasive diagnosis of endometriosis
2016
Proteolytic processing of human brain alpha spectrin (fodrin): identification of a hypersensitive site
1988
Flexible and Stretchable Physical Sensor Integrated Platforms for Wearable Human‐Activity Monitoringand Personal Healthcare
2016 Standout
Muscle actin filaments bind pituitary secretory granules in vitro.
1977
Stimulation of Adenosine 3′:5′-Cyclic Monophosphate Accumulation in Anterior Pituitary Gland In Vitro by Synthetic Luteinizing Hormone-Releasing Hormone
1972 StandoutNobel
Multiple receptors for dopamine
1979 StandoutNature
DIRECT INHIBITION OF GASTRIC ACID AND PEPSIN SECRETION BY GROWTH-HORMONE RELEASE-INHIBITING HORMONE IN CATS
1975 StandoutNobel
Endometriosis
2020 Standout
SYNTHESIS, INTRACELLULAR TRANSPORT AND DISCHARGE OF EXPORTABLE PROTEINS IN THE PANCREATIC ACINAR CELL AND OTHER CELLS
1978
Stabilizing Infrastructure of Cell Membranes
1985
In vivo phosphorylation of the lamin B receptor. Binding of lamin B to its nuclear membrane receptor is affected by phosphorylation.
1990 StandoutNobel
Regulation of Steroidogenic Acute Regulatory Protein Expression and Progesterone Production in Endometriotic Stromal Cells
2001
Androgens in Men — Uses and Abuses
1996
Intracellular Aspects of the Process of Protein Synthesis
1975 StandoutScienceNobel
Actin from Saccharomyces cerevisiae
1982 StandoutNobel
Secreton and uptake of peroxidase by rat adenohypophyseal cells
1973
LAPAROSCOPIC COAGULATION OF MYOMA (MYOLYSIS)
1995
Isolation and functional expression of a mammalian prohormone processing enzyme, murine prohormone convertase 1.
1991 StandoutNobel
Suppression of Gonadotropins and Estradiol in Premenopausal Women by Oral Administration of the Nonpeptide Gonadotropin-Releasing Hormone Antagonist Elagolix
2008
Physiological role of somatostatin in the control of growth hormone and thyrotropin secretion
1976 StandoutNobel
The binding of vimentin to human erythrocyte membranes: a model system for the study of intermediate filament-membrane interactions.
1985
Elliptical erythrocyte membrane skeletons and heat-sensitive spectrin in hereditary elliptocytosis.
1981
Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release.
1978 StandoutNobel
Insulin synthesis in a clonal cell line of simian virus 40-transformed hamster pancreatic beta cells.
1981
The insulin-like growth factor system in human peritoneal fluid: its effects on endometrial stromal cells and its potential relevance to endometriosis.
1994
A molecular defect in two families with hemolytic poikilocytic anemia: reduction of high affinity membrane binding sites for ankyrin.
1981 StandoutNobel
Inhibition of growth hormone and thyrotropin release by growth hormone-release inhibiting hormone
1974 StandoutNobel
Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal growth factor.
1979 StandoutNobel
Dopamine Receptors: From Structure to Function
1998 Standout
Inhibition of adenosine 3′,5′-monophosphate accumulation in anterior pituitary gland in vitro by growth hormone-release inhibiting hormone
1974 StandoutNobel
Response : Nitric Oxide and Arginine-Evoked Insulin Secretion
1992 StandoutScienceNobel
A Prospective Study of Inflammatory Markers and Risk of Endometriosis
2017
Deficient Red-Cell Spectrin in Severe, Recessively Inherited Spherocytosis
1982 StandoutNobel
Works of André Lemay being referenced
Comparative Effect of Danazol and a GnRH Agonist on Monocyte Chemotactic Protein‐1 Expression by Endometriotic Cells
2001
Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis
1988
Physiological and Cytogenetic Characterization of Immortalized Human Endometriotic Cells Containing Episomal Simian Virus 40 DNA
1999
Calcium‐dependent stimulation of prolactin release in rat anterior pituitaryin vitro by n6‐monobutyryl adenosine 3′,5′‐monophosphate
1972
Cytokine-induced secretion of monocyte chemotactic protein-1 by human endometriotic cells in culture
1995
Increased monocyte chemotactic protein-1 level and activity in the peripheral blood of women with endometriosis
1996
Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol
1991
Dose-related inhibition of acute luteinizing hormone response during luteinizing hormone-releasing hormone agonist treatment for uterine leiomyoma
1988
Imbalance in the peritoneal levels of interleukin 1 and its decoy inhibitory receptor type II in endometriosis women with infertility and pelvic pain
2007
Effect of hormonal agents on monocyte chemotactic protein-1 expression by endometrial epithelial cells of women with endometriosis
2000
Immunoblot Detection of Decreased Antibodies to Haptoglobin-Like Protein in the Serum of Infertile Women with or without Endometriosis1
1997
Mitogen(s) for endometrial-like cells can be detected in human peritoneal fluid
1991
Clinical efficacy and safety of low‐dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism
1995
N-terminal truncated forms of insulin-like growth factor binding protein-3 in the peritoneal fluid of women without laparoscopic evidence of endometriosis
1995
The Relevance of the Women’s Health Initiative Results on Combined Hormone Replacement Therapy in Clinical Practice
2002
Attenuation of Mild Hyperandrogenic Activity in Postpubertal Acne by a Triphasic Oral Contraceptive Containing Low Doses of Ethynyl Estradiol and d,l-Norgestrel
1990
A randomized, double-blind, placebo-controlled study on the effect of conjugated estrogens on skin thickness
1994
Immunohistochemical localization of insulin-like growth factor–binding protein-3 in eutopic and ectopic endometrial tissues
1999
Maintained reduction of uterine leiomyoma following addition of hormonal replacement therapy to a monthly luteinizing hormone-releasing hormone agonist implant: a pilot study
1991
Antifertility Effects of LHRH Agonists in the Male
1980
Phosphorylation of Adenohypophyseal Plasma Membranes and Properties of Associated Protein Kinase
1974
Use of intranasal luteinizing hormone-releasing hormone agonist in uterine leiomyomas.
1987
Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist
1982
Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial
2007
Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men
1982
Regression of leiomyomata uteri following hypoestrogenism induced by repetitive luteinizing hormone-releasing hormone agonist treatment: preliminary report
1984
Heparin-sepharose binding growth factors in peritoneal fluid of women with endometriosis
1993
The distribution of spectrin along the membranes of normal and echinocytic human erythrocytes
1978
Secretion of monocyte chemotactic protein-1 by cytokine-stimulated endometrial cells of women with endometriosis
1995
Role of Microtubules in Basal and Stimulated Release of Growth Hormone and Prolactin in Rat Adenohypophysisin Vitro
1973
Somatostatin inhibition of insulin release from freshly isolated and organ cultured rat islets of langerhans in vitro
1975
Ultrastructural Changes Accompanying the Stimulatory Effect of N6-Monobutyryl Adenosine 3’,5’-Monophosphate on the Release of Growth Hormone (GH), Prolactin (PRL) and Adrenocorticotropic Hormone (ACTH) in Rat Anterior Pituitary Glandin Vitro
1972
Elevated concentration and biologic activity of monocyte chemotactic protein-1 in the peritoneal fluid of patients with endometriosis
1996
Use of intranasal luteinizing hormone-releasing hormone agonist in uterine leiomyomas
1987
CONTROL OF PROTEIN SYNTHESIS IN ANTERIOR PITUITARY GLAND
1973
Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: A pilot study
1985
LH-RH agonist treatment of endometriosis.
1987
Estradiol and Interleukin-1β Exert a Synergistic Stimulatory Effect on the Expression of the Chemokine Regulated upon Activation, Normal T Cell Expressed, and Secreted in Endometriotic Cells
2002
Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis
1984
Purification of Adenohypophyseal Plasma Membranes and Properties of Associated Adenylate Cyclase
1974
Specific fragmentation of human erythrocyte spectrin by chemical cleavage at cysteine residues
1979
A randomized, controlled trial of a low-dose contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for acne treatment
2001